Leading Companies Enhancing Their Presence in the Cell Processing Technologies Market

The cell processing technologies industry is on the brink of significant expansion, driven by advancements in cell therapies and personalized medicine. As innovations continue to transform this sector, it is important to understand the market's projected growth, key players, emerging trends, and how the market segments are evolving to meet growing demands.

Projected Market Size and Growth Potential in Cell Processing Technologies
The cell processing technologies market is poised to experience remarkable growth, expected to reach $9.24 billion by 2030. This represents an impressive compound annual growth rate (CAGR) of 13.5% over the forecast period. Several factors contribute to this surge, including the increasing commercialization of cell therapies, a higher demand for scalable cell manufacturing processes, and the widening applications of personalized medicine. Additional drivers include growing investments in bioprocess automation and an intensified regulatory focus on maintaining stringent cell processing standards. Key market trends anticipated through this period involve the expanding use of automated cell processing systems, rising preference for closed-system cell handling technologies, integration of digital process monitoring tools, broader adoption of single-use consumables, and a stronger emphasis on maintaining cell viability and quality control.

Download a free sample of the cell processing technologies market report:
https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Top Companies Leading the Cell Processing Technologies Market
Several influential companies are at the forefront of the cell processing technologies market, playing vital roles in its evolution. These include Thermo Fisher Scientific Inc., Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton inson and Company, Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG, Sartorius Stedim Biotech, and Cytiva.

Recent Strategic Acquisition in Cell Processing Technologies
In a strategic move to expand its cell therapy manufacturing capabilities, StemCell Technologies Canada Inc. acquired Cellular Highways Ltd. in June 2025. Although the financial details remain undisclosed, this acquisition is significant as it will integrate Cellular Highways' cutting-edge cell sorting technology, notably the VACS-powered Highway1 instrument, into StemCell's operations. Cellular Highways Ltd., based in the UK, specializes in developing advanced cell processing technologies for both research and therapeutic purposes, making this acquisition an important step in enhancing innovative solutions within the cell processing field.

The cell processing technologies industry is on the brink of significant expansion, driven by advancements in cell therapies and personalized medicine. As innovations continue to transform this sector, it is important to understand the market's projected growth, key players, emerging trends, and how the market segments are evolving to meet growing demands.

Projected Market Size and Growth Potential in Cell Processing Technologies
The cell processing technologies market is poised to experience remarkable growth, expected to reach $9.24 billion by 2030. This represents an impressive compound annual growth rate (CAGR) of 13.5% over the forecast period. Several factors contribute to this surge, including the increasing commercialization of cell therapies, a higher demand for scalable cell manufacturing processes, and the widening applications of personalized medicine. Additional drivers include growing investments in bioprocess automation and an intensified regulatory focus on maintaining stringent cell processing standards. Key market trends anticipated through this period involve the expanding use of automated cell processing systems, rising preference for closed-system cell handling technologies, integration of digital process monitoring tools, broader adoption of single-use consumables, and a stronger emphasis on maintaining cell viability and quality control.

Download a free sample of the cell processing technologies market report:
https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Leading the Cell Processing Technologies Market
Several influential companies are at the forefront of the cell processing technologies market, playing vital roles in its evolution. These include Thermo Fisher Scientific Inc., Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton inson and Company, Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG, Sartorius Stedim Biotech, and Cytiva.

Recent Strategic Acquisition in Cell Processing Technologies
In a strategic move to expand its cell therapy manufacturing capabilities, StemCell Technologies Canada Inc. acquired Cellular Highways Ltd. in June 2025. Although the financial details remain undisclosed, this acquisition is significant as it will integrate Cellular Highways' cutting-edge cell sorting technology, notably the VACS-powered Highway1 instrument, into StemCell's operations. Cellular Highways Ltd., based in the UK, specializes in developing advanced cell processing technologies for both research and therapeutic purposes, making this acquisition an important step in enhancing innovative solutions within the cell processing field.

Emerging Trends Influencing the Cell Processing Technologies Industry
Leading companies in the broader life sciences and related sectors are focusing on the development of technologically sophisticated solutions to address critical industry needs. An example is the next-generation TSX technology, which advances haptic feedback and touch sensitivity in various applications such as gaming, smartphones, virtual reality, and wearables, while also supporting users with disabilities. This trend towards highly specialized and efficient technology reflects a broader industry push towards nuanced, high-performance solutions.

Innovations in the Cell Processing Market with Practical Applications
For instance, in February 2024, ZimVie, a US-based life sciences company, introduced its next-generation TSX dental implant in Japan. This implant is engineered for immediate extraction and standard loading procedures, offering enhanced placement predictability and primary stability across diverse bone types. Drawing on over 20 years of clinical data, the implant is designed to support peri-implant health and long-term osseointegration while featuring a hybrid surface that reduces the risk of peri-implantitis. This launch strengthens ZimVie's competitive standing against premium market leaders in the dental implant sector, showcasing how innovation drives market differentiation.

Detailed Market Segmentation and Forecasts for Cell Processing Technologies
The cell processing technologies market is divided into various segments to better understand its scope and growth areas:
1) Product Type: Equipment, Consumables, and Software
2) Application Areas: Oncology, Cardiovascular Disease, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Immune Diseases, and Other Applications
3) End-User Categories: Pharmaceutical and Biotechnology Companies, Academic Research Institutes, and Other End-Users

Further product subdivisions include:
- Equipment such as bioreactors, centrifuges, cell counters, incubators, cryopreservation systems, cell washers, cell sorters, and microscopes
- Consumables including cell culture media, reagents, pipettes and tips, flasks and plates, cryovials, filters, disposable bags, tubes, and containers
- Software encompassing process monitoring, data management, automation control, quality control, imaging and analysis, and inventory management programs

This thorough segmentation provides a clear perspective on the multiple facets of the market and highlights where future growth and innovation are expected to occur.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.